The total cost of developing, manufacturing, testing, and marketing a generic drug in India costs just 20% to 40% of the expenses in the West. A Glimpse of the API…
The post How to find a reputable API supplier appeared first on DrugPatentWatch – Make …
The financial risks of being found liable for patent infringement are astronomically high Developing a strategy for the development, production and the final launch of a new drug is a…
The post How to Conduct a Drug Patent FTO Search appeared first on …
There is a strong incentive to find out new opportunities for the discovery of new drugs Annual sales in the pharmaceutical sector have been increasing in the double-digit range for…
The post Using drug patent information to synthesize drugs appeared f…
Using drug patent information to synthesize drugs Read Post »
What is Data Exclusivity? In 1984, the USA was the first country to give legal sanctity to data exclusivity via the Hatch-Waxman Act. Under this new legislation five years of…
The post Data Exclusivity: Is there a happy medium? appeared first on DrugPa…
Drug prices are mysterious and unpredictable for many consumers With the average person’s out-of-pocket expense for a drug determined by several interdependent factors, planning for care is harder, and trying…
The post Deconstructing Drug Pricing Strat…
Deconstructing Drug Pricing Strategy for Big Pharma Read Post »
Biologic drugs are far more complex than traditional “small molecule” drugs Generic drugs as we know them differ from biosimilars, which are designed to be less costly alternatives to branded biologic drugs.…
The post Exploring Biosimilars as a Drug Pa…
Drug repositioning offers an alternative path to drug development Researchers at the US drug group Pfizer’s Sandwich research center while working on an angina treatment found a compound by the…
The post Using clinical trial information to forecast fut…
Using clinical trial information to forecast future therapeutic indications Read Post »
The time and expense involved with introducing a new drug can be phenomenal Whether the “blockbuster drug” era is over, as some claim, or not, coming up with brand new…
The post Leveraging Patent Pending Data for Pharmaceuticals appeared first on DrugP…
Leveraging Patent Pending Data for Pharmaceuticals Read Post »
Data from clinical trials can improve pharmaceutical forecasting Pharmaceutical investing requires a level of attention to detail that is not as critical in less complex or less regulated industries. The…
The post How Clinical Trial Data Supports Accur…
How Clinical Trial Data Supports Accurate Pharma Forecasting Read Post »
Pharmaceutical manufacturing can benefit from expired or abandoned patents Abandoned and expired patents can have outstanding potential for pharmaceutical manufacturing. Patents confer a set of exclusive rights for a defined…
The post Abandoned and Exp…
Abandoned and Expired Patents in Pharma Manufacturing Read Post »